Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenqi Yichang Formula (SQYCF) is a Traditional Chinese Medicine (TCM) herbal decoction developed by the Jiangsu Province Hospital of Integrated Chinese and Western Medicine for the treatment of colorectal cancer and colorectal adenocarcinoma. The formula is primarily composed of several botanical ingredients, including *Astragalus membranaceus* (Huangqi) and *Panax ginseng* (Renshen), which are traditionally used to tonify Qi and strengthen the spleen. Modern pharmacological research indicates that SQYCF exerts its anti-tumor effects by inhibiting the epithelial-mesenchymal transition (EMT) and suppressing the migration and invasion of cancer cells. This mechanism is largely mediated through the modulation of the TGF-β/Smad signaling pathway, specifically by reducing the expression of TGF-β1 and the phosphorylation of SMAD2 and SMAD3. SQYCF is often utilized as an adjuvant therapy to improve clinical outcomes and quality of life in patients with colorectal malignancies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shenqi Yichang Formula.